Orbimed Advisors Llc bought $3.5M of Electra Therapeutics (ETRA)

Executed Nov 3, disclosed Nov 5, 2 days later.

Value, as filed

$3.5M

458,304 sh across 8 lots

Executed

Nov 3

the trade date, as filed

Disclosed

Nov 5

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

OL Orbimed Advisors Llc Director profile →

Orbimed Advisors Llc (Director) filed 18 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 8 sales, 1 filed past the two-business-day deadline), most often in Sionna Therapeutics, Inc. (SION). Across 8 priced purchase filings, the average 21-session return was +11.7% from execution and +14.6% from disclosure (delay-adjusted; derived). The largest single filing was $38.9M of ELVN (858,646 sh across 3 lots, as filed), executed Jun 22.

The name

ETRA

Electra Therapeutics, Inc. ETRA · Healthcare · 4 filings in 24 months ticker →

Healthcare · Electra Therapeutics, Inc. is a clinical-stage biotechnology company

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Orbimed Advisors Llc in ETRA

ETRAPURCHASE Electra Therapeutics, Inc. $20.0M
1,333,333 sh across 2 lots
Exec Sep 21
Filed Sep 23 · 5:29 PM ET